Product
methotrexate
4 clinical trials
4 indications
Indication
HypophosphatasiaIndication
Head and Neck NeoplasmsIndication
GoutIndication
PsoriasisClinical trial
An Interventional, Prospective Open-Label Study of Immunosuppressive Therapies to Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia (RESTORE)Status: Not yet recruiting, Estimated PCD: 2028-04-28
Clinical trial
A Randomised, Open-label, Phase III Study to Evaluate the Efficacy and Safety of Oral Afatinib (BIBW 2992) Versus Intravenous Methotrexate in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Who Have Progressed After Platinum-based Therapy.Status: Active (not recruiting), Estimated PCD: 2018-08-22
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Randomized Controlled Trial [RCT])Status: Completed, Estimated PCD: 2021-03-17
Clinical trial
A Multicenter, Randomized, Double-Blind, Double-Dummy, Active Controlled Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisStatus: Completed, Estimated PCD: 2021-11-26